{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T11:16:05Z","timestamp":1794741365792,"version":"4.9.1"},"reference-count":47,"publisher":"American Diabetes Association","issue":"6","license":[{"start":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:00:00Z","timestamp":1630022400000},"content-version":"vor","delay-in-days":3024,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,6,1]]},"abstract":"<jats:p>The estrogen receptor \u03b2 (ER\u03b2) is emerging as an important player in the physiology of the endocrine pancreas. We evaluated the role and antidiabetic actions of the ER\u03b2 selective agonist WAY200070 as an insulinotropic molecule. We demonstrate that WAY200070 enhances glucose-stimulated insulin secretion both in mouse and human islets. In vivo experiments showed that a single administration of WAY200070 leads to an increase in plasma insulin levels with a concomitant improved response to a glucose load. Two-week treatment administration increased glucose-induced insulin release and pancreatic \u03b2-cell mass and improved glucose and insulin sensitivity. In addition, streptozotocin-nicotinamide\u2013induced diabetic mice treated with WAY200070 exhibited a significant improvement in plasma insulin levels and glucose tolerance as well as a regeneration of pancreatic \u03b2-cell mass. Studies performed in db\/db mice demonstrated that this compound restored first-phase insulin secretion and enhanced pancreatic \u03b2-cell mass. We conclude that ER\u03b2 agonists should be considered as new targets for the treatment of diabetes.<\/jats:p>","DOI":"10.2337\/db12-1562","type":"journal-article","created":{"date-parts":[[2013,1,25]],"date-time":"2013-01-25T03:52:20Z","timestamp":1359085940000},"page":"2015-2025","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":53,"title":["Antidiabetic Actions of an Estrogen Receptor \u03b2 Selective Agonist"],"prefix":"10.2337","volume":"62","author":[{"given":"Paloma","family":"Alonso-Magdalena","sequence":"first","affiliation":[{"name":"Institute of Bioengineering and Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders, Miguel Hernandez University of Elche, Alicante, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana B.","family":"Ropero","sequence":"additional","affiliation":[{"name":"Institute of Bioengineering and Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders, Miguel Hernandez University of Elche, Alicante, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Garc\u00eda-Ar\u00e9valo","sequence":"additional","affiliation":[{"name":"Institute of Bioengineering and Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders, Miguel Hernandez University of Elche, Alicante, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Soriano","sequence":"additional","affiliation":[{"name":"Institute of Bioengineering and Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders, Miguel Hernandez University of Elche, Alicante, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Quesada","sequence":"additional","affiliation":[{"name":"Institute of Bioengineering and Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders, Miguel Hernandez University of Elche, Alicante, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarheed J.","family":"Muhammed","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Lund University, Malm\u00f6, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Salehi","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Lund University, Malm\u00f6, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Ake","family":"Gustafsson","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Biochemistry, Center for Nuclear Receptors and Cell Signaling, University of Houston, Houston, Texas"},{"name":"Department of Biosciences and Nutrition, Karolinska Institut, Huddinge, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"Nadal","sequence":"additional","affiliation":[{"name":"Institute of Bioengineering and Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders, Miguel Hernandez University of Elche, Alicante, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2013,5,17]]},"reference":[{"key":"2022031210320622200_B1"},{"key":"2022031210320622200_B2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","article-title":"Global estimates of the prevalence of diabetes for 2010 and 2030","volume":"87","author":"Shaw","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"2022031210320622200_B3","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00125-009-1321-z","article-title":"The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality","volume":"52","author":"Kahn","year":"2009","journal-title":"Diabetologia"},{"key":"2022031210320622200_B4","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1172\/JCI29103","article-title":"Islet beta cell failure in type 2 diabetes","volume":"116","author":"Prentki","year":"2006","journal-title":"J Clin Invest"},{"key":"2022031210320622200_B5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1463-1326.2009.01113.x","article-title":"Towards better understanding of the contributions of overwork and glucotoxicity to the beta-cell inadequacy of type 2 diabetes","volume":"11","author":"Weir","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"2022031210320622200_B6","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.2165\/00003495-200868150-00005","article-title":"New drugs for type 2 diabetes mellitus: what is their place in therapy?","volume":"68","author":"Krentz","year":"2008","journal-title":"Drugs"},{"key":"2022031210320622200_B7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tips.2010.10.003","article-title":"Emerging therapies in the treatment of \u2018diabesity\u2019: beyond GLP-1","volume":"32","author":"Tharakan","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"2022031210320622200_B8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1463-1326.2009.01095.x","article-title":"Future perspectives for insulinotropic agents in the treatment of type 2 diabetes-DPP-4 inhibitors and sulphonylureas","volume":"12","author":"Gallwitz","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"2022031210320622200_B9","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.2741\/3532","article-title":"Pharmacogenetics and future strategies in treating hyperglycaemia in diabetes","volume":"14","author":"Pearson","year":"2009","journal-title":"Front Biosci"},{"key":"2022031210320622200_B10","doi-asserted-by":"crossref","first-page":"e2069","DOI":"10.1371\/journal.pone.0002069","article-title":"Pancreatic insulin content regulation by the estrogen receptor ER alpha","volume":"3","author":"Alonso-Magdalena","year":"2008","journal-title":"PLoS ONE"},{"key":"2022031210320622200_B11","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1210\/me.2009-0287","article-title":"Rapid regulation of K(ATP) channel activity by 17beta-estradiol in pancreatic beta-cells involves the estrogen receptor beta and the atrial natriuretic peptide receptor","volume":"23","author":"Soriano","year":"2009","journal-title":"Mol Endocrinol"},{"key":"2022031210320622200_B12","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nrd3551","article-title":"Development of subtype-selective oestrogen receptor-based therapeutics","volume":"10","author":"Nilsson","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"2022031210320622200_B13","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tem.2010.05.001","article-title":"ERbeta: recent understanding of estrogen signaling","volume":"21","author":"Sugiyama","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"2022031210320622200_B14","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrc3093","article-title":"The different roles of ER subtypes in cancer biology and therapy","volume":"11","author":"Thomas","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"2022031210320622200_B15","doi-asserted-by":"crossref","first-page":"15677","DOI":"10.1073\/pnas.95.26.15677","article-title":"Generation and reproductive phenotypes of mice lacking estrogen receptor beta","volume":"95","author":"Krege","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022031210320622200_B16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejphar.2011.01.015","article-title":"Effects of antidiabetic drugs in high-fat diet and streptozotocin-nicotinamide-induced type 2 diabetic mice","volume":"655","author":"Tahara","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"2022031210320622200_B17","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.metabol.2008.10.012","article-title":"Antidiabetic effects of dipeptidyl peptidase-IV inhibitors and sulfonylureas in streptozotocin-nicotinamide-induced mildly diabetic mice","volume":"58","author":"Matsuyama-Yokono","year":"2009","journal-title":"Metabolism"},{"key":"2022031210320622200_B18","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1096\/fasebj.12.13.1341","article-title":"Rapid insulinotropic effect of 17beta-estradiol via a plasma membrane receptor","volume":"12","author":"Nadal","year":"1998","journal-title":"FASEB J"},{"key":"2022031210320622200_B19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1113\/jphysiol.1992.sp019295","article-title":"The relationship between glucose-induced K+ATP channel closure and the rise in [Ca2+]i in single mouse pancreatic beta-cells","volume":"455","author":"Valdeolmillos","year":"1992","journal-title":"J Physiol"},{"key":"2022031210320622200_B20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ceca.2005.10.005","article-title":"Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell","volume":"39","author":"Juan-Pic\u00f3","year":"2006","journal-title":"Cell Calcium"},{"key":"2022031210320622200_B21","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"2022031210320622200_B22","doi-asserted-by":"crossref","first-page":"e31109","DOI":"10.1371\/journal.pone.0031109","article-title":"Rapid insulinotropic action of low doses of bisphenol-A on mouse and human islets of Langerhans: role of estrogen receptor \u03b2","volume":"7","author":"Soriano","year":"2012","journal-title":"PLoS ONE"},{"key":"2022031210320622200_B23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cmet.2011.08.005","article-title":"Estrogen receptors and the metabolic network","volume":"14","author":"Barros","year":"2011","journal-title":"Cell Metab"},{"key":"2022031210320622200_B24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.mce.2009.02.016","article-title":"The pancreatic beta-cell as a target of estrogens and xenoestrogens: implications for blood glucose homeostasis and diabetes","volume":"304","author":"Nadal","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"2022031210320622200_B25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2337\/db11-1033","article-title":"Synergistic reversal of type 1 diabetes in NOD mice with anti-CD3 and interleukin-1 blockade: evidence of improved immune regulation","volume":"61","author":"Ablamunits","year":"2012","journal-title":"Diabetes"},{"key":"2022031210320622200_B26","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1073\/pnas.0610787104","article-title":"Silencing of estrogen receptor alpha in the ventromedial nucleus of hypothalamus leads to metabolic syndrome","volume":"104","author":"Musatov","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022031210320622200_B27","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/sj.ijo.0802054","article-title":"Estrogen receptor beta is involved in the anorectic action of estrogen","volume":"26","author":"Liang","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2022031210320622200_B28","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s00125-005-0105-3","article-title":"Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver","volume":"49","author":"Bryzgalova","year":"2006","journal-title":"Diabetologia"},{"key":"2022031210320622200_B29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1677\/JOE-08-0192","article-title":"The estrogen receptor alpha-selective agonist propyl pyrazole triol improves glucose tolerance in ob\/ob mice; potential molecular mechanisms","volume":"199","author":"Lundholm","year":"2008","journal-title":"J Endocrinol"},{"key":"2022031210320622200_B30","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1073\/pnas.0510391103","article-title":"Muscle GLUT4 regulation by estrogen receptors ERbeta and ERalpha","volume":"103","author":"Barros","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022031210320622200_B31","doi-asserted-by":"crossref","first-page":"31292","DOI":"10.1074\/jbc.M110.147850","article-title":"Estrogen receptor-beta-selective ligands alleviate high-fat diet- and ovariectomy-induced obesity in mice","volume":"285","author":"Yepuru","year":"2010","journal-title":"J Biol Chem"},{"key":"2022031210320622200_B32","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1210\/en.2010-1361","article-title":"Insulinotropic and antidiabetic effects of 17\u03b2-estradiol and the GPR30 agonist G-1 on human pancreatic islets","volume":"152","author":"Kumar","year":"2011","journal-title":"Endocrinology"},{"key":"2022031210320622200_B33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.mce.2010.01.030","article-title":"Activation of G protein-coupled receptor 30 modulates hormone secretion and counteracts cytokine-induced apoptosis in pancreatic islets of female mice","volume":"320","author":"Balhuizen","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"2022031210320622200_B34","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1210\/en.2011-0091","article-title":"Mechanisms of estradiol-induced insulin secretion by the G protein-coupled estrogen receptor GPR30\/GPER in pancreatic beta-cells","volume":"152","author":"Sharma","year":"2011","journal-title":"Endocrinology"},{"key":"2022031210320622200_B35","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.2337\/db09-0257","article-title":"Importance of extranuclear estrogen receptor-alpha and membrane G protein-coupled estrogen receptor in pancreatic islet survival","volume":"58","author":"Liu","year":"2009","journal-title":"Diabetes"},{"key":"2022031210320622200_B36","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1073\/pnas.74.6.2485","article-title":"Studies of streptozotocin-induced insulitis and diabetes","volume":"74","author":"Rossini","year":"1977","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022031210320622200_B37","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1742-7843.2008.00321.x","article-title":"Hypoglycaemic effects of antidiabetic drugs in streptozotocin-nicotinamide-induced mildly diabetic and streptozotocin-induced severely diabetic rats","volume":"103","author":"Tahara","year":"2008","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2022031210320622200_B38","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.taap.2010.08.020","article-title":"Beneficial effect of 17\u03b2-estradiol on hyperglycemia and islet \u03b2-cell functions in a streptozotocin-induced diabetic rat model","volume":"249","author":"Yamabe","year":"2010","journal-title":"Toxicol Appl Pharmacol"},{"key":"2022031210320622200_B39","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1677\/joe.0.0620439","article-title":"Short-term effects of oestradiol benzoate in normal, hypophysectomized and alloxan-diabetic male rats","volume":"62","author":"Goodman","year":"1974","journal-title":"J Endocrinol"},{"key":"2022031210320622200_B40","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1172\/JCI44564","article-title":"Estrogen receptor activation reduces lipid synthesis in pancreatic islets and prevents \u03b2 cell failure in rodent models of type 2 diabetes","volume":"121","author":"Tiano","year":"2011","journal-title":"J Clin Invest"},{"key":"2022031210320622200_B41","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1210\/en.2004-1653","article-title":"Estrogen and exercise may enhance beta-cell function and mass via insulin receptor substrate 2 induction in ovariectomized diabetic rats","volume":"146","author":"Choi","year":"2005","journal-title":"Endocrinology"},{"key":"2022031210320622200_B42","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1210\/en.2009-1294","article-title":"Genistein induces pancreatic beta-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in mice","volume":"151","author":"Fu","year":"2010","journal-title":"Endocrinology"},{"key":"2022031210320622200_B43","doi-asserted-by":"crossref","first-page":"230870","DOI":"10.1155\/2012\/230870","article-title":"Islet \u03b2-Cell mass preservation and regeneration in diabetes mellitus: four factors with potential therapeutic interest","volume":"2012","author":"Mellado-Gil","year":"2012","journal-title":"J Transplant"},{"key":"2022031210320622200_B44","doi-asserted-by":"crossref","first-page":"5824","DOI":"10.1210\/jcem.86.12.8105","article-title":"Importance of early phase insulin secretion to intravenous glucose tolerance in subjects with type 2 diabetes mellitus","volume":"86","author":"Kahn","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031210320622200_B45","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.2337\/diabetes.51.2007.S117","article-title":"Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes?","volume":"51","author":"Gerich","year":"2002","journal-title":"Diabetes"},{"key":"2022031210320622200_B46","doi-asserted-by":"crossref","first-page":"E124","DOI":"10.1152\/ajpendo.00189.2009","article-title":"Participation of ERalpha and ERbeta in glucose homeostasis in skeletal muscle and white adipose tissue","volume":"297","author":"Barros","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031210320622200_B47","doi-asserted-by":"crossref","first-page":"e1000108","DOI":"10.1371\/journal.pgen.1000108","article-title":"Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma","volume":"4","author":"Foryst-Ludwig","year":"2008","journal-title":"PLoS Genet"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/62\/6\/2015\/570699\/2015.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/62\/6\/2015\/570699\/2015.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:34:30Z","timestamp":1667406870000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/62\/6\/2015\/15946\/Antidiabetic-Actions-of-an-Estrogen-Receptor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,17]]},"references-count":47,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,5,17]]},"published-print":{"date-parts":[[2013,6,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db12-1562","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,17]]}}}